All-cause mortality in relation to glycated haemoglobin in individuals with newly diagnosed type 2 diabetes: A retrospective cohort study

British Journal of Diabetes and Vascular Disease

Volumn 13, Issue 1, 2013, Pages 22-30

  Khunti, Kamlesh ^a   Weston, Claire ^a   Gholap, Nitin ^a   Molokhia, Mariam ^b   Paul, Sanjoy ^c   Millett, Christopher ^d   Curcin, Vasa ^d   Majeed, Azeem ^d   Davies, Melanie J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular Disease; HbA1C; Mortality; New type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK REDUCTION;

EID: 84875723453     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651412468297     Document Type: Article

References (25)

1. Mainous AG, Diaz V, Everett C, Koopman R, Saxena S, Baker R, et al. Impact of the population at-risk for diabetes on projections of diabetes burden in the United States. Diabetologia. 2007 ; 50: 934-40
2. Roper NA, Bilous R, Kelly W, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 2001 ; 322: 1389-93
3. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000 ; 321: 405-12
4. Gerstein H, Pogue J, Mann JFE, Lonn E, Dagenais GR, McQueen M, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia. 2005 ; 48: 1749-55
5. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus. Ann Intern Med. 2004 ; 141: 421-31
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 ; 359: 1577-89
7. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 2008 ; 358: 2545-59
8. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 ; 358: 2560-72
9. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 ; 360: 129-39
10. Majeed A. Sources, uses, strengths and limitations of data collected in primary care in England. HSQ. 2004 ; 21: 5-14
11. Department of Communities and Local Government. 2004 (revised) Index of multiple deprivation. http://www.communities.gov.uk/publications/communities/ englishindices. Accessed 28 January 2011.
12. De Lusignan S, Khunti K, Belsey J, Hattersley A, Van Vlymen J, Gallagher H, et al. A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabetic Med. 2010 ; 27: 203-9
13. De Lusignan S. Codes, Classifications, terminologies and nomenclatures: definition, development and application in practice. Informatics in Primary Care. 2005 ; 13: 65-9
14. Maru S, Koch GG, Stender M, Stender M, Clark D, Gibowski L, et al. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the UK primary care setting. Diabetes Care. 2005 ; 28: 20-6
15. Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 1999 ; 281: 427-31
16. Collett D. Modelling survival data in medical research. London: Chapman and Hall; 1994.
17. Executive Summary: Standards of Medical Care in Diabetes 2010. Diabetes Care. 2010 ; 33: S4 - S10
18. National Institute for Clinical Excellence: Clinical guidelines for type 2 diabetes mellitus: management of blood glucose (update). http://www.nice.org. uk/CG066. Accessed 17 February 2011.
19. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 ; 352: 854-65
20. Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009 ; 52: 2288-98
21. Currie C, Peters JR, Tynan A, Evans M, Heine RJ. Survival as a function of HbA1C in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010 ; 375: 481-9
22. Khunti K, Gadsby R, Millett C, Majeed A, Davies M. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med. 2007 ; 24: 1436-41
23. Khan NF, Harrison S, Rose P. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010 ; 60: e128-136
24. Bonds DE, Miller M, Bergenstal R, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010 ; 340: B4909
25. Zoungas S, Patel A, Chalmers J, de Galan BE, Qiang L, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010 ; 363: 1410-8